Announced
Completed
Synopsis
Sartorius Stedim Biotech, a international partner of the biopharmaceutical industry, completed the acquisition of chromatography process equipment division from Novasep, a provider of services in the field of molecule production and purification for the life science industries. Financial terms were not disclosed. "The Novasep portfolio will perfectly complement our existing chromatography offering and allow us to provide customers with more options for their manufacturing processes. Efficient downstream processing has remained a challenge in our industry for years, and Sartorius Stedim Biotech is committed to helping accelerate and simplify this crucial step so that new drugs can be manufactured much more efficiently," René Fáber, Sartorius Stedim Biotech Member of the Board of Directors.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.